Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterizing a rat Brca2 knockout model.

M S Cotroneo1, J D Haag, Y Zan

  • 1McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.

Oncogene
|September 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo.

Experimental eye research·2022
Same author

Corrigendum to "Comparison of ultrasonic pachymetry and Fourier-domain optical coherence tomography for measurement of corneal thickness in dogs with and without corneal disease" [Vet. J. 242 (2018) 59-66].

Veterinary journal (London, England : 1997)·2020
Same author

Improved two-dimensional electrophoretic mapping of Japanese human hair proteins; application to curved and straight Japanese human hairs; and protein identification by MALDI MS and MS/MS quadrupole time-of-flight mass spectrometry.

International journal of cosmetic science·2020
Same author

Comparison of ultrasonic pachymetry and Fourier-domain optical coherence tomography for measurement of corneal thickness in dogs with and without corneal disease.

Veterinary journal (London, England : 1997)·2018
Same author

Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.

Colloids and surfaces. B, Biointerfaces·2017
Same author

Controlling selectivity in the Ullmann reaction on Cu(111).

Chemical communications (Cambridge, England)·2017
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

A new rat model with a BRCA2 gene mutation shows viability despite altered growth and sterility. This model aids research into BRCA2

Area of Science:

  • Genetics and Genomics
  • Cancer Biology
  • Animal Models

Background:

  • Individuals with BRCA2 gene mutations have increased risks for several cancers.
  • Mouse models of BRCA2 deficiency exhibit limited survival.
  • A rat model with a nonsense mutation in BRCA2 (Brca2-/-) was previously developed.

Purpose of the Study:

  • To characterize the phenotype of the Brca2 knockout rat.
  • To investigate the role of BRCA2 in cancer susceptibility and novel phenotypes.

Main Methods:

  • Generation of a rat strain with a nonsense mutation in exon 11 of the BRCA2 gene.
  • Phenotypic analysis of Brca2-/- rats, including viability, growth, fertility, and tumor development.
  • Histopathological examination of affected tissues.

Related Experiment Videos

Main Results:

  • Brca2-/- rats are viable and live over 1 year, unlike Brca2-/- mice.
  • Phenotypes include growth inhibition, sterility (due to failed homologous chromosome synapsis), underdeveloped mammary glands, cataracts, and shortened lifespan with multi-organ tumors.
  • The rat model exhibits a novel ocular phenotype not previously linked to BRCA2.

Conclusions:

  • The Brca2 knockout rat is a viable model for studying BRCA2 function and cancer susceptibility.
  • This model reveals new insights into BRCA2's role in development, fertility, and ocular health.
  • The rat model offers a valuable tool for preclinical research on BRCA2-associated cancers and related conditions.